New ADA Guidelines 2025: What Changed in Diabetes Care

New ADA Guidelines 2025: What Changed in Diabetes Care

The American Diabetes Association (ADA) has released its annual update to the Standards of Care in Diabetes, the premier guide for healthcare professionals in the management of diabetes. The 2025 edition reflects the latest evidence and expert consensus, introducing several key changes that will shape the future of diabetes care. This article provides a summary of the most significant updates.

Emphasis on Technology and Time-in-Range

A major theme in the 2025 Standards of Care is the expanded role of technology in diabetes management. The guidelines now place a greater emphasis on the use of continuous glucose monitoring (CGM) for a wider range of patients, not just those on intensive insulin therapy.

The concept of Time-in-Range (TIR), a metric derived from CGM data, is now more formally recognized as a key indicator of glycemic control. TIR represents the percentage of time a person spends with their blood glucose levels within a target range. The guidelines provide specific TIR targets for different patient populations, acknowledging that TIR is a valuable complement to the traditional A1C measurement.

Person-Centered and Inclusive Language

Continuing a trend from previous years, the 2025 guidelines reinforce the importance of using person-centered and inclusive language. The ADA advocates for a shift away from labels like "diabetic" and towards language that respects the individual, such as "person with diabetes." This change is intended to reduce stigma and empower individuals in their own care.

Updates in Pharmacological Treatment

The recommendations for medication have been updated to reflect the latest clinical trial data. There is a continued emphasis on the use of newer classes of medications, such as SGLT2 inhibitors and GLP-1 receptor agonists, for their proven cardiovascular and kidney benefits, independent of their glucose-lowering effects. The guidelines provide more nuanced recommendations for the selection of these agents based on a patient's individual risk factors and comorbidities.

Focus on Older Adults

The 2025 Standards of Care include a dedicated section on the management of diabetes in older adults, recognizing the unique challenges in this population. The guidelines stress the importance of individualized glycemic targets, taking into account factors such as functional status, cognitive function, and risk of hypoglycemia. There is a greater focus on simplifying treatment regimens and de-prescribing medications when appropriate to reduce the risk of adverse events.

Key Takeaways

• The 2025 ADA Standards of Care place a greater emphasis on technology, particularly Continuous Glucose Monitoring (CGM) and Time-in-Range (TIR).
• The guidelines continue to advocate for person-centered and inclusive language.
• There are updated recommendations for the use of SGLT2 inhibitors and GLP-1 receptor agonists for their cardiovascular and renal benefits.
• There is a heightened focus on individualized care for older adults with diabetes.

What the Research Says

The annual updates to the ADA Standards of Care are based on a rigorous review of the latest scientific evidence by a committee of experts in the field. The 2025 guidelines reflect a growing body of research that supports a more personalized and technology-driven approach to diabetes management. The emphasis on TIR, for example, is backed by studies showing its correlation with the risk of long-term complications.

Practical Considerations

For individuals with diabetes, these updated guidelines may lead to conversations with their healthcare providers about:

• The potential benefits of using a CGM device.
• New medication options that may offer additional health benefits beyond blood sugar control.
• Adjusting glycemic targets to better suit their individual needs and circumstances.

Safety & Disclaimers

This article provides a general overview of the 2025 ADA Standards of Care and is not a substitute for professional medical advice. Individuals with diabetes should always consult with their healthcare team to determine the best course of treatment for them.

Source Log

1. American Diabetes Association. (2024). The American Diabetes Association Releases Standards of Care in Diabetes—2025. https://diabetes.org/newsroom/press-releases/american-diabetes-association-releases-standards-care-diabetes-2025
2. American Diabetes Association. (2025). Summary of Revisions: Standards of Care in Diabetes—2025. Diabetes Care, 48(Supplement_1), S6-S12. https://doi.org/10.2337/dc25-SREV
3. American Diabetes Association. (2025). Standards of Care in Diabetes—2025. Diabetes Care, 48(Supplement_1).
4. Tiwari, D. (2025). Updates from the 2025 American Diabetes Association Standards of Care. Exploration of Endocrinology and Metabolic Disease.
5. Time in Range. (2025). Time in Range in the 2025 ADA Standards of Care. https://www.timeinrange.org/time-in-range-in-the-2025-ada-standards-of-care/